The "U.S. Dermatological Drugs Market Size, Share & Trends Analysis Report by Therapy (Acne, Psoriasis), Type (Prescription, Over-The-Counter), Route of Administration, Drug Class, Distribution Channel with Growth Forecasts, 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The U.S. Dermatological Drugs Market was valued at USD 8.32 billion in 2024, and is projected to reach USD 14.48 billion by 2030, rising at a CAGR of 9.70%
The growth of the market is driven by the availability of novel treatments designed for chronic skin diseases and the increasing prevalence of skin problems such as acne, psoriasis, and others. Increasing awareness regarding the significance of skin health in overall well-being also contributes to the growth.
Moreover, significant investments in research and development lead to new medications, and the availability of over-the-counter products makes treatments more accessible, contributing to overall growth. In recent years, multiple pharmaceutical and consumer healthcare companies have received U.S. FDA approvals for innovation-based products developed to treat severe skin conditions and enhance patient outcomes.
The emergence of new drug delivery systems and key market participants turning to collaboration-based research efforts in dermatology have also played vital roles in the market's growth. The large number of individuals seeking affordable treatments, the availability of over-the-counter products across retail pharmacies, and retailer service expansions with novel offerings such as fast delivery and online distribution are projected to add lucrative growth opportunities for this market over the forecast period.
U.S. Dermatological Drugs Market Report Highlights
- Psoriasis dominated the therapy segment with more than 35.0% share in 2024, owing to many individuals seeking effective treatment for psoriasis and the focus of market participants on the delivery of novel therapies
- Dermatological drugs for acne are expected to grow at a significant CAGR in the U.S. over the forecast period
- The prescription-based dermatological drugs held the largest market share, 77.5%, in 2024. The over-the-counter segment is anticipated to witness significant growth over the forecast period
- Topical administration dominated the U.S. dermatological drugs market, with a revenue share of 60.0% in 2024, owing to patients' treatment experiences, patient-friendly delivery systems, and ease of use. The parenteral administration segment is expected to witness the fastest CAGR of 10.7% over the forecast period
- Increasing investments in research and development, approvals received for numerous novel therapies and products, and convenience offered by retail pharmacies are contributing to the growth of the U.S. dermatological drugs market.
Companies Featured
- AbbVie Inc.
- Pfizer Inc.
- GSK plc.
- LEO Pharma A/S
- Sun Pharmaceutical Industries Ltd.
- GALDERMA
- Amgen Inc.
- Johnson & Johnson Services Inc.
- Novartis AG
- Eli Lilly and Company
- Almirall, S.A
- Bausch Health Companies Inc.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $8.32 Billion |
| Forecasted Market Value (USD) by 2030 | $14.48 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | United States |
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.6. Information Analysis
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Dermatological Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter's Five Forces Analysis
3.3.2. PESTLE Analysis
Chapter 4. U.S. Dermatological Drugs Market: Therapy Estimates & Trend Analysis
4.1. Therapy Market Share, 2024 & 2030
4.2. Therapy Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
4.4. Acne
4.4.1. Acne Market, 2018-2030 (USD Million)
4.5. Psoriasis
4.6. Rosacea
4.7. Alopecia
4.8. Others
Chapter 5. U.S. Dermatological Drugs Market: Type Estimates & Trend Analysis
5.1. Type Market Share, 2024 & 2030
5.2. Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
5.4. Prescription
5.5. Over-the-Counter (OTC)
Chapter 6. U.S. Dermatological Drugs Market: Route of Administration Estimates & Trend Analysis
6.1. Route of Administration Market Share, 2024 & 2030
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Topical Administration
6.5. Oral Administration
6.6. Parenteral Administration
Chapter 7. U.S. Dermatological Drugs Market: Drug Class Estimates & Trend Analysis
7.1. Drug Class Channel Market Share, 2024 & 2030
7.2. Drug Class Channel Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
7.4. Corticosteroids
7.5. Retinoids
7.6. Antibiotics
7.7. Antifungals
7.8. Calcineurin Inhibitors
Chapter 8. U.S. Dermatological Drugs Market: Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel Market Share, 2024 & 2030
8.2. Distribution Channel Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
8.4. Hospital Pharmacies
8.5. Retail Pharmacies
8.6. Ohers
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
For more information about this report visit https://www.researchandmarkets.com/r/fy6llq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250617645058/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
